Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia

Details for Australian Patent Application No. 2004283091 (hide)

Owner Allergan, Inc.

Inventors Graham, Richard; Olejnik, Orest; Bakhit, Peter G.

Agent Davies Collison Cave

Pub. Number AU-A-2004283091

PCT Pub. Number WO2005/039619

Priority 60/508,445 03.10.03 US

Filing date 25 August 2004

Wipo publication date 6 May 2005

International Classifications

A61K 31/5575 (2006.01)

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/039619 Priority application(s): WO2005/039619

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283093-Compounds and compositions as protein kinase inhibitors

2004283087-Solid pharmaceutical dosage form